Reklama
twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

Sopharma AD: Current report 18 re insiders transactions (2016-02-15)

|
selectedselectedselected
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
wykop

UNI-EN 18:SPHTR Current report 18 re insiders transactions

Firma: SOPHARMA AD
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SPHTRCurrent report 18 re insiders transactions.doc SPHTR Current report 18 re insiders transactions

POLISH FINANCIAL SUPERVISION AUTHORITY









UNI - EN REPORT No 18 / 2016





Date of issue: 2016-02-15
Short name of the issuer
SOPHARMA AD
Subject
SPHTR Current report 18 re insiders transactions
Official market - legal basis
Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych
Unofficial market - legal basis
Contents of the report:
Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Sopharma Trading AD" related to him, executed the following transactions related to shares in the Company:


Date and time of the settlement Operation Number of shares Unit price (BGN)
10.2.2016 Buy 200 2.5950
10.2.2016 Buy 300 2.6000
10.2.2016 Buy 364 2.6000
10.2.2016 Buy 364 2.6000
10.2.2016 Buy 364 2.6000
10.2.2016 Buy 272 2.6000
10.2.2016 Buy 680 2.6000
10.2.2016 Buy 320 2.6000
11.2.2016 Buy 1 000 2.6000
11.2.2016 Buy 500 2.6000
12.2.2016 Buy 158 2.6000
12.2.2016 Buy 742 2.6000
12.2.2016 Buy 416 2.6000
12.2.2016 Buy 584 2.6000
12.2.2016 Buy 70 2.5800
12.2.2016 Buy 1 930 2.5800
12.2.2016 Buy 500 2.5800
12.2.2016 Buy 500 2.5800
12.2.2016 Buy 1 000 2.5800
12.2.2016 Buy 35 2.5720
12.2.2016 Buy 420 2.5800
12.2.2016 Buy 1 000 2.5800
12.2.2016 Buy 100 2.6000
12.2.2016 Buy 2 000 2.5800
12.2.2016 Buy 1 145 2.5800
12.2.2016 Buy 100 2.6000
12.2.2016 Buy 855 2.5800
12.2.2016 Buy 655 2.5800
12.2.2016 Buy 1 345 2.5800
15.2.2016 Buy 500 2.5800
15.2.2016 Buy 1 000 2.5700
15.2.2016 Buy 260 2.5690
15.2.2016 Buy 290 2.5690
15.2.2016 Buy 170 2.5700
16.2.2016 Buy 100 2.5950
16.2.2016 Buy 348 2.5950
16.2.2016 Buy 352 2.5950
16.2.2016 Buy 396 2.5950
16.2.2016 Buy 452 2.5950
16.2.2016 Buy 452 2.5950
16.2.2016 Buy 452 2.5950
16.2.2016 Buy 92 2.5950
16.2.2016 Buy 56 2.5950
16.2.2016 Buy 452 2.5950
16.2.2016 Buy 436 2.5950
16.2.2016 Buy 360 2.5950
16.2.2016 Buy 752 2.5950
16.2.2016 Buy 1 000 2.5950
16.2.2016 Buy 1 000 2.5700
16.2.2016 Buy 100 2.5700
16.2.2016 Buy 2 000 2.5700


The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade.
Annexes
File Description
SPHTRCurrent report 18 re insiders transactions.doc
SPHTRCurrent report 18 re insiders transactions.doc
SPHTR Current report 18 re insiders transactions

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2016-02-15 Ognian Donev Executive director

Cena akcji Sopharma

Cena akcji Sopharma w momencie publikacji komunikatu to 5.9 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.

W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.

Jesteś dziennikarzem i szukasz pracy? Napisz do nas

Masz lekkie pióro? Interesujesz się gospodarką i finansami? Możliwe, że szukamy właśnie Ciebie.

Zgłoś swoją kandydaturę

Reklama